ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $284,490 | -45.1% | 21,800 | -25.9% | 0.00% | -25.0% |
Q4 2022 | $518,616 | -80.8% | 29,400 | -83.4% | 0.00% | -82.6% |
Q3 2022 | $2,705,000 | +188.1% | 177,630 | +180.6% | 0.02% | +155.6% |
Q2 2022 | $939,000 | +53.9% | 63,294 | +133.6% | 0.01% | +80.0% |
Q1 2022 | $610,000 | -57.8% | 27,100 | -75.0% | 0.01% | -66.7% |
Q3 2021 | $1,447,000 | +152.5% | 108,234 | +249.1% | 0.02% | +150.0% |
Q2 2021 | $573,000 | +274.5% | 31,000 | +192.5% | 0.01% | +200.0% |
Q4 2020 | $153,000 | -50.6% | 10,600 | -66.4% | 0.00% | -75.0% |
Q4 2019 | $310,000 | +53.5% | 31,535 | +48.8% | 0.01% | +14.3% |
Q1 2019 | $202,000 | -81.6% | 21,200 | -76.8% | 0.01% | -88.1% |
Q2 2018 | $1,097,000 | +36.4% | 91,400 | +40.3% | 0.06% | -1.7% |
Q1 2018 | $804,000 | +462.2% | 65,150 | +549.4% | 0.06% | +361.5% |
Q3 2017 | $143,000 | -36.4% | 10,032 | -43.3% | 0.01% | -74.0% |
Q2 2016 | $225,000 | – | 17,703 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |